BELLUS Health (OTCMKTS:BLUSF) Sets New 52-Week High at $8.14

Shares of BELLUS Health Inc (OTCMKTS:BLUSFGet Rating) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $8.14 and last traded at $8.10, with a volume of 554521 shares traded. The stock had previously closed at $7.95.

The business’s fifty day moving average is $8.13 and its 200 day moving average is $7.04.

BELLUS Health Company Profile (OTCMKTS:BLUSF)

BELLUS Health, Inc is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

See Also

Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.